Literature DB >> 28685198

[Geriatric urology : Increasingly important in urological care].

A Wiedemann1.   

Abstract

Urology will benefit by demographic change more than other disciplines in the next 10 years. Both number of patients and their intensity of treatment will increase. This implies the need of a reorientation of urology away from oncologic topics towards geriatric urology. Relevant issues are functional disorders of the lower urinary tract, infectiology, hematuria, and benign prostate hyperplasia. The legislature of North Rhine-Westphalia has already made the first step towards geriatric urology by the foundation of the ISAR screening for each geriatric patient outside geriatrics, which constitutes the possibility of beginning an early interdisciplinary dialogue. Considering the geriatric patient as being defined by age, multimorbidity, multimedication, and the resulting vulnerability, there are new fields of work in urology. These lie in research areas such as cognitive alterations after urologic surgery or medications and the adjustment of urologic methods to the specific requirements of these patients.

Entities:  

Keywords:  Anticholinergic agents; Cognition; Prostate syndrome, benign; Urinary tract, lower; Urogeriatrics

Mesh:

Year:  2017        PMID: 28685198     DOI: 10.1007/s00120-017-0438-9

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  3 in total

1.  10-Year Outcomes in Localized Prostate Cancer.

Authors:  Freddie C Hamdy; Jenny L Donovan; David E Neal
Journal:  N Engl J Med       Date:  2017-01-12       Impact factor: 91.245

2.  Detection of older people at increased risk of adverse health outcomes after an emergency visit: the ISAR screening tool.

Authors:  J McCusker; F Bellavance; S Cardin; S Trépanier; J Verdon; O Ardman
Journal:  J Am Geriatr Soc       Date:  1999-10       Impact factor: 5.562

3.  [Potential cognitive alterations after treatment of benign prostate syndrome. Investigations on transurethral electroresection and 180 W GreenLight XPS laser therapy].

Authors:  A Wiedemann; R Maykan; J Pennekamp; J Hirsch; H Heppner
Journal:  Z Gerontol Geriatr       Date:  2014-10-07       Impact factor: 1.281

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.